Component with abundant immune-related cells in combined hepatocellular cholangiocarcinoma identified by cluster

Naoki Yagi1,2,3, Toshihiro Suzuki1,4, Shoichi Mizuno1

  • 1Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.

Cancer Science
|February 28, 2022
PubMed

Related Concept Videos